SAN DIEGO and TOKYO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today announced that the Company has received approval for the Celution Cell Therapy System consumable bundle in Japan as a Class III …
TORONTO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- DatametrexAI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G) is pleased to announce the voting results of its 2018 Annual and Special Meeting of Shareholders held in Toronto on November 30, 2018. …
A number of large shareholders have confirmed to Paulson that they are voting for wholesale change Shareholders urged to vote using only the GOLD proxy and submit prior to 5:00 p.m. (Toronto time) on Thursday, December 6, 2018 NEW YORK, Dec. 03, 2018 ( …
Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting LUGANO, Switzerland and San Diego, USA, December 3, 2018: Helsinn …
Achieved statistical significance on primary imaging-based endpoint, changes in markers of central pain processing, in 11 subjects Observed corresponding trends of improvement on multiple secondary endpoints, including average daily pain scores and the …
LONDON, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Horizonte Minerals Plc, (AIM: HZM, TSX: HZM) (‘Horizonte’ or ‘the Company’), announces that on 29 and 30 November 2018, William Fisher, Non-Executive Director of the Company, purchased 175,000 ordinary shares of 1p …
NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Zillow Group, Inc. (NASDAQ:Z), YRC …
HOUSTON, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today …
NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Wayfair Inc. (NYSE:W), TEGNA Inc. ( …
PORTLAND, Ore. and SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Oregon Health & Science University (OHSU) and Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) today announced the presentation of preclinical data demonstrating that CG-806, a first-in- …
Dublin, Dec. 03, 2018 (GLOBE NEWSWIRE) -- The "Air Brake System Market by Type (Disc & Drum), Component (Compressor, Governor, Tank, Air Dryer, Foot Valve, Brake Chamber & Slack Adjuster), Rolling Stock, Vehicle Type (Rigid Body, Heavy-Duty, …
SAN DIEGO and TORONTO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) today announced the presentation of preclinical data from research led by The University of Texas MD Anderson Cancer Center exploring the mechanism by …
-- 27% of subjects achieved 75% reduction in PASI score (PASI 75) vs 13% with vehicle; 29% of subjects achieved two-grade improvement on IGA and ‘clear’ or ‘almost clear’ skin vs 13% with vehicle (statistically significant) -- Subjects achieved 58% …
LONDON and WALTHAM, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and TESARO Inc (NASDAQ: TSRO) today announced that the Companies have entered into a definitive agreement pursuant to which GSK will acquire TESARO, an …
Combined power of Rulebook acquisition and Sequel enhances Verisk's position as a leading provider of insurance software solutions to the global specialty market JERSEY CITY, N.J., December 3, 2018 - Verisk (Nasdaq:VRSK), a leading data analytics …
WAYNE, Pa. and SAN JOSE, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- DLL, a global provider of flexible financing solutions and Propelics, an Anexinet company, and leader in enterprise mobile strategy and world-class app development, today announced that the …
EDMONTON, Alberta, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Atlas Growers Ltd. (“Atlas”), a wholly owned subsidiary of Atlas Biotechnologies Inc. announces that it has recently received an expansion to activities permitted under its initial Producer’s licence ( …
The ERADICATE Hp2 confirmatory Phase 3 study successfully met its primary endpoint of H. pylori eradication (84% vs. 58%) with high degree of statistical significance (p<0.0001) High resistance to standard-of-care antibiotics observed in the ERADICATE …
TORONTO, ONTARIO, CANADA, December 3, 2018 /EINPresswire.com/ -- Media Release, Monday, December 3, 2018 John Harris Receives Cashbox Legacy Award Sandy Graham, CEO/Editor in Chief of Cashbox Magazine Canada, presented John Harris, founder of …
TORONTO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that new clinical data from the ongoing …
05 days 04:53:18
